- Home
- WALD vs PALI Comparison
WALD vs PALI Comparison
Compare WALD & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- PALI
- Stock Information
- Founded
- WALD 1988
- PALI 1996
- Country
- WALD United States
- PALI United States
- Employees
- WALD N/A
- PALI N/A
- Industry
- WALD Package Goods/Cosmetics
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WALD Consumer Discretionary
- PALI Health Care
- Exchange
- WALD Nasdaq
- PALI Nasdaq
- Market Cap
- WALD 228.8M
- PALI 212.0M
- IPO Year
- WALD 2021
- PALI N/A
- Fundamental
- Price
- WALD $1.82
- PALI $1.69
- Analyst Decision
- WALD Strong Buy
- PALI Strong Buy
- Analyst Count
- WALD 5
- PALI 2
- Target Price
- WALD $4.96
- PALI $12.00
- AVG Volume (30 Days)
- WALD 45.9K
- PALI 4.7M
- Earning Date
- WALD 11-11-2025
- PALI 11-11-2025
- Dividend Yield
- WALD N/A
- PALI N/A
- EPS Growth
- WALD N/A
- PALI N/A
- EPS
- WALD N/A
- PALI N/A
- Revenue
- WALD $273,868,000.00
- PALI N/A
- Revenue This Year
- WALD $10.37
- PALI N/A
- Revenue Next Year
- WALD $14.37
- PALI N/A
- P/E Ratio
- WALD N/A
- PALI N/A
- Revenue Growth
- WALD 25.55
- PALI N/A
- 52 Week Low
- WALD $1.48
- PALI $0.53
- 52 Week High
- WALD $4.18
- PALI $3.30
- Technical
- Relative Strength Index (RSI)
- WALD 48.21
- PALI 49.96
- Support Level
- WALD $1.64
- PALI $1.77
- Resistance Level
- WALD $1.96
- PALI $2.14
- Average True Range (ATR)
- WALD 0.13
- PALI 0.18
- MACD
- WALD -0.00
- PALI -0.06
- Stochastic Oscillator
- WALD 47.50
- PALI 25.60
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.